Enter inventor name

Stockbridge, MI, United States of America

Patrick Michael O'Brien

This inventor holds 29 USPTO granted patents and 1 published patent application, primarily in Matrix Metalloproteinase Inhibitors. Top assignees: Warner-Lambert Company, Reata Pharmaceuticals, Inc.. Active years: 1992-2024.

USPTO Granted Patents = 29 (Patent Applications = 1)

% Patents Active = 51.7

Average Co-Inventor Count = 3.8

ph-index = 9

Forward Citations = 311(Granted Patents)

Location History:

Northville, MI (US) (1992)
Stockbridge, MI (US) (1994 - 2017)
Irving, TX (US) (2024)

Company Filing History:

26 out of 2,538

Warner-Lambert Company

patents

4 out of 63

Reata Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1992-2024

Loading Chart...

Areas of Expertise:

Matrix Metalloproteinase Inhibitors

ACAT Inhibitors

Anti-Inflammatory Compounds

Pyrazole Compounds

Imidazole Compounds

Natural Product Analogs

Hetero Biaryl Derivatives

Phenylene Alkynes

Tricyclic Sulfonamides

Hydroxamic Acid Compounds

Biphenyl Sulfonamides

Fluorinated Butyric Acids

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11993574 - Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma (2024-05-28),

2. 9796668 - Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use (2017-10-24),

3. 9233998 - Natural product analogs including an anti-inflammatory cyanoenone pharmacore and methods of use (2016-01-12),

4. 8258329 - Dehydroandrosterone analogs including an anti-inflammatory pharmacore and methods of use (2012-09-04),

5. 7179822 - Hetero biaryl derivatives as matrix metalloproteinase inhibitors (2007-02-20),

6. 7015237 - Pyridine matrix metalloproteinase inhibitors (2006-03-21),

7. 6906094 - 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase (2005-06-14),

8. 6906092 - Method of inhibiting matrix metalloproteinases (2005-06-14),

9. 6881743 - Pyridine matrix metalloproteinase inhibitors (2005-04-19),

10. 6849648 - Phenylene alkyne matrix metalloproteinase inhibitors (2005-02-01),

11. 6686355 - Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors (2004-02-03),

12. 6677355 - Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors (2004-01-13),

13. 6624177 - Matrix metalloproteinase inhibitors and their therapeutic uses (2003-09-23),

14. 6620835 - Method of inhibiting matrix metalloproteinases (2003-09-16),

15. 6559142 - Sulfonamide matrix metalloproteinase inhibitors (2003-05-06),

Title: The Inventor Patrick Michael O'Brien

Introduction: Patrick Michael O'Brien, a talented inventor hailing from Stockbridge, MI (US), has made significant contributions to the field of innovation with his creative ideas and groundbreaking inventions.

Latest Patents: Patrick Michael O'Brien holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on improving sustainability in packaging solutions and enhancing user experience in mobile applications.

Career Highlights: Throughout his career, Patrick Michael O'Brien has been recognized for his innovative thinking and problem-solving skills. He has received multiple awards for his inventions, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Patrick Michael O'Brien has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have led to the successful development and commercialization of cutting-edge products that have made a positive impact on society.

Conclusion: In conclusion, Patrick Michael O'Brien's passion for innovation and commitment to excellence have established him as a prominent figure in the world of inventors. His relentless pursuit of new ideas continues to inspire others in the industry to think outside the box and create a better future for all.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]